Vascular barrier protective effects of 3-N- or 3-O-cinnamoyl carbazole derivatives

  • Sae Kwang Ku
  • , Jee Hyun Lee
  • , O. Yuseok
  • , Wonhwa Lee
  • , Gyu Yong Song
  • , Jong Sup Bae

Research output: Contribution to journalArticlepeer-review

Abstract

In this Letter, we investigated the barrier protective effects of 3-N-(MeO)n-cinnamoyl carbazoles (BS 1; n = 1, BS 2; n = 2, BS 3; n = 3) and 3-O-(MeO)3-cinnamoyl carbazole (BS 4) against high-mobility group box 1 (HMGB1)-mediated vascular disruptive responses in human umbilical vein endothelial cells (HUVECs) and in mice for the first time. Data showed that BS 2, BS 3, and BS 4, but not BS 1, inhibited HMGB1-mediated vascular disruptive responses and transendothelial migration of human neutrophils to HUVECs. BS 2, BS3, and BS 4 also suppressed HMGB1-induced hyperpermeability and leukocyte migration in mice. Interestingly, the barrier protective effects of BS 3 and BS 4 were better than those of BS 2. These results suggest that the number of methoxy groups substituted on the cinnamamide or cinnamate moiety of the 9H-3-carbazole derivative is an important pharmacophore for the barrier protective effects of these compounds.

Original languageEnglish
Pages (from-to)4304-4307
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume25
Issue number19
DOIs
StatePublished - 1 Oct 2015
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • 3-N-Cinnamoyl carbazole
  • 3-O-Cinnamoyl carbazole
  • HMGB1
  • Vascular barrier integrity

Fingerprint

Dive into the research topics of 'Vascular barrier protective effects of 3-N- or 3-O-cinnamoyl carbazole derivatives'. Together they form a unique fingerprint.

Cite this